Welcome to our dedicated page for CTEK news (Ticker: CTEK), a resource for investors and traders seeking the latest updates and insights on CTEK stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect CTEK's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of CTEK's position in the market.
CynergisTek, Inc. (CTEK) announced stockholder approval of a merger agreement with Clearwater Compliance LLC, valued at approximately $17.7 million. During the virtual special meeting, stockholders approved the acquisition in an all-cash transaction of $1.25 per share. The merger is expected to close on September 1, 2022, after which CynergisTek shares will cease trading on the NYSE American Stock Market, transitioning the company to a private entity. Full voting results will be disclosed in a Form 8-K filing with the SEC.
CynergisTek (AMEX:CTEK), a leader in cybersecurity and compliance, has secured contract extensions worth over $300,000 with a prominent medical device manufacturer. This renewal extends their seven-year partnership into 2023, facilitating compliance across 150 countries. The firm will provide comprehensive Data Privacy Program Support services to enhance risk management and compliance for their client. CynergisTek's growth reflects its commitment to exceeding client expectations and adapting to new regulatory requirements.
CynergisTek, Inc. (CTEK) announced a significant multi-year agreement to enhance cybersecurity for a southwest healthcare system with over 25 locations. The Resilience Partner Program (RPP) includes risk assessments, penetration testing, and advisory services aimed at improving the client’s cybersecurity posture. Selected over numerous competitors, this contract highlights the program's tailored approach and addresses the increasing demands for cybersecurity amid evolving threats. CEO Mac McMillan emphasized the investment in proactive cybersecurity measures as essential for strengthening resilience.
CynergisTek, Inc. will hold a special meeting for stockholders on August 31, 2022, to vote on the proposed merger with Clearwater Compliance LLC. The merger, valued at approximately $17.7 million, aims to strengthen CynergisTek's position in cybersecurity and compliance for regulated industries. Stockholders eligible to vote must do so based on the record date of July 15, 2022. The Board of Directors recommends voting in favor of the merger agreement as outlined in the Definitive Proxy Statement filed with the SEC.
CynergisTek has renewed its partnership with a leading academic medical center in California, extending its services for more than a decade. The multi-year extension involves providing the Compliance Assist Partner Program (CAPP) and Vendor Security Management (VSM) services. These services include enterprise risk assessments, advisory services, and assessments of third-party risks. CynergisTek aims to enhance the cybersecurity posture and compliance of its client.
CynergisTek has signed contracts worth over
CynergisTek, Inc. (CTEK) announces the expiration of the "go-shop" period related to its merger agreement with Clearwater Compliance LLC, valuing the company at approximately $17.7 million. The Board has not determined the received acquisition proposal as a "Superior Proposal," resulting in customary "no-shop" restrictions. The merger agreement remains in effect, with CynergisTek scheduled to submit the proposal to stockholders for consideration at a special meeting. All related materials will be filed with the SEC, including a definitive proxy statement.
CynergisTek (CTEK) announces the expiration of the initial 'go-shop' period related to its merger agreement with Clearwater Compliance, valuing CTEK at approximately $17.7 million. During this period, the company contacted 88 potential buyers, leading to one acquisition proposal. The board has not yet deemed the proposal as superior and continues to support the merger agreement. Despite receiving interest, no definitive transaction is assured, and the company remains committed to the current merger terms, rejecting alternative acquisition offers.
CynergisTek (AMEX: CTEK) has announced a six-figure extension contract with a leading pediatric healthcare system on the west coast. The contract focuses on enhancing cybersecurity measures through risk assessment, vendor security management, and incident response services. As healthcare organizations face growing cybersecurity challenges, CynergisTek continues to offer comprehensive support to help clients improve their security posture and mitigate risks. The firm emphasizes proactive risk management and the importance of effective safeguards against cyber threats.
CynergisTek (NYSE American: CTEK) has secured a six-figure deal with a Midwest health system, marking its first collaboration with strategic partner GroupSense. The agreement focuses on ransomware readiness and dark web monitoring. CynergisTek will enhance the client’s cybersecurity posture by monitoring public personas and providing 24/7 incident support. This partnership aims to empower healthcare institutions to proactively combat online threats, leveraging advanced monitoring capabilities to safeguard businesses and patients.
